The Linear No-Threshold Theory of Radiation Carcinogenesis should be Rejected. The Linear No-Threshold Theory of Radiation Carcinogenesis should be Rejected.

The Linear No-Threshold Theory of Radiation Carcinogenesis should be Rejected‪.‬

Journal of American Physicians and Surgeons 2008, Fall, 13, 3

    • $5.99
    • $5.99

Publisher Description

It is commonly stated that "any radiation dose, no matter how small, can cause cancer." The basis for that statement is the linear-no threshold theory (LNT)--which might more appropriately be called "linear-no threshold hypothesis"--of radiation carcinogenesis. According to LNT, if a 1 Gy (100 rad) dose gives a cancer risk R, the risk from a dose of 0.01 Gy (1 rad) is R/ 100, the risk from 0.00001 Gy (1 millirad) is R/100,000, and so on. Thus the cancer risk is not zero regardless of how small the dose. However, over the past several years, many radiation health scientists have come to regard risk estimates in the low-dose region based on LNT as exaggerated or completely negligible. For example, the 6,000-member Health Physics Society, the principal organization for radiation protection scientists, issued a position paper (1) stating: "Below 10 rad... risks of health effects are either too small to be observed or are nonexistent." A similar position statement was issued by the American Nuclear Society. When the Health Physics Society Newsletter asked for submission of comments on validity of LNT, there were about 20 negative comments submitted and only a single comment supportive of LNT. In a worldwide poll conducted by the principal on-line discussion group of radiation protection professionals (RADSAFE), the vote was 118 to 12 against LNT. A 2001 Report by the French Academy of Medicine concluded that LNT is "without any scientific validity," and an elaborate joint study by the French Academy of Medicine and the French Academy of Sciences (2) strongly condemned the use of LNT.

GENRE
Business & Personal Finance
RELEASED
2008
September 22
LANGUAGE
EN
English
LENGTH
30
Pages
PUBLISHER
Association of American Physicians and Surgeons, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
297
KB
"Obamacare": What Is in It (Barack Obama's Health Care Reform) "Obamacare": What Is in It (Barack Obama's Health Care Reform)
2010
Extrathyroidal Benefits of Iodine. Extrathyroidal Benefits of Iodine.
2006
Lessons from Sweden's Universal Health System: Tales from the Health-Care Crypt. Lessons from Sweden's Universal Health System: Tales from the Health-Care Crypt.
2008
The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease (Report) The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease (Report)
2009
Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report) Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report)
2009
Obamacare Policy Myths: Warnings from a 1980S HMO Executive (Essay) Obamacare Policy Myths: Warnings from a 1980S HMO Executive (Essay)
2010